Omzet 2024 * | 2,72 mld. 10,09 mld. 2,53 mld. | Omzet 2025 * | 3,05 mld. 11,31 mld. 2,84 mld. | Marktkapitalisatie | 13,92 mld. 51,59 mld. 12,94 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 439 mln. 1,63 mld. 408 mln. | Nettowinst (verlies) 2025 * | 528 mln. 1,96 mld. 491 mln. | EV/omzet 2024 * | 4,63 x |
Nettoliquiditeiten 2024 * | 1,32 mld. 4,88 mld. 1,22 mld. | Nettoliquiditeiten 2025 * | 2,15 mld. 7,97 mld. 2 mld. | EV/omzet 2025 * | 3,86 x |
K/w-verhouding 2024 * |
33,7
x | K/w-verhouding 2025 * |
27,7
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,28% | 81,91 mld. | |
+3,40% | 76,64 mld. | |
-16,54% | 52,31 mld. | |
+35,85% | 51,96 mld. | |
-22,85% | 47,77 mld. | |
+23,11% | 43,3 mld. | |
+64,59% | 38,29 mld. | |
-9,36% | 24,89 mld. | |
-14,17% | 25,1 mld. |